Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?

被引:52
作者
Grossfeld, GD [1 ]
Latini, DM
Downs, T
Lubeck, DP
Mehta, SS
Carroll, PR
机构
[1] Univ Calif San Francisco, Dept Urol, Program Urol Oncol, Urol Outcomes Res Grp, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Mt Zion Canc Ctr, San Francisco, CA 94143 USA
[3] TAP Pharmaceut Prod Inc, Lake Forest, IL USA
关键词
prostate; prostatic neoplasms; blacks; questionnaires; neoplasm recurrence; local;
D O I
10.1016/S0022-5347(05)64179-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Prostate cancer incidence and mortality are higher in black than in white American men. We determined whether ethnicity is an independent predictor of disease recurrence in men undergoing radical prostatectomy. Materials and Methods: We studied 1,468 patients who underwent radical prostatectomy at the University of California, San Francisco or as part of the Cancer of the Prostate Strategic Urological Research Endeavor database, a longitudinal disease registry of patients with prostate cancer. Preoperative characteristics, including age, race, prostate specific antigen (PSA) at diagnosis, clinical T stage, biopsy Gleason score and percent positive prostate biopsies at diagnosis were determined in each patient. Disease recurrence was defined as PSA 0.2 ng./ml. or greater on 2 consecutive occasions after radical prostatectomy or second cancer treatment at least 6 months after surgery. Cox proportional hazards analysis was performed to determine independent predictors of time to disease recurrence. To control for pretreatment disease characteristics simultaneously patients were assigned to previously described risk groups based on clinical tumor stage, PSA at diagnosis and biopsy Gleason score. The likelihood of disease recurrence per risk group stratified according to ethnicity was determined using the Kaplan-Meier method and compared using the log rank test. Additional multivariate analysis was performed in the subset of patients enrolled in Cancer of the Prostate Strategic Urological Research Endeavor on whom education and income information was available. Results: Disease recurred in 304 of the 1,468 patients (21%). Black ethnicity, serum PSA at diagnosis, biopsy Gleason score and percent positive prostate biopsies were independent predictors of recurrence on multivariate analysis. Black ethnicity remained an independent predictor of disease recurrence in the multivariate model after stratifying patients into risk groups (p = 0.0007). Ethnicity was most important in patients at high risk, in whom estimated 5-year disease-free survival was 65% and 28% in white and black men, respectively. Education, income and ethnicity correlated highly. When education and income were entered into the multivariate model, ethnicity was no longer an independent predictor of outcome after prostatectomy. Conclusions: Ethnicity appears to be an independent predictor of disease recurrence after adjusting for pretreatment measures of disease extent in patients undergoing radical prostatectomy. It appears to be particularly important in those with high risk disease characteristics. However, black ethnicity, education and income are highly correlated variables, suggesting that sociodemographic factors may contribute to the poorer outcomes in black patients even after adjusting for differences in pretreatment disease characteristics.
引用
收藏
页码:2510 / 2515
页数:6
相关论文
共 22 条
[11]   Health related quality of life differences between black and white men with prostate cancer: Data from the cancer of the prostate strategic urologic research endeavor [J].
Lubeck, DP ;
Kim, H ;
Grossfeld, C ;
Ray, P ;
Penson, DF ;
Flanders, SC ;
Carroll, PR .
JOURNAL OF UROLOGY, 2001, 166 (06) :2281-2285
[12]  
Mandelblatt JS, 1999, CANCER-AM CANCER SOC, V86, P2378, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2378::AID-CNCR28>3.3.CO
[13]  
2-C
[14]   Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting [J].
Moul, JW ;
Douglas, TH ;
McCarthy, WF ;
McLeod, DG .
JOURNAL OF UROLOGY, 1996, 155 (05) :1667-1672
[15]   PROSTATE-SPECIFIC ANTIGEN VALUES AT THE TIME OF PROSTATE-CANCER DIAGNOSIS IN AFRICAN-AMERICAN MEN [J].
MOUL, JW ;
SESTERHENN, IA ;
CONNELLY, RR ;
DOUGLAS, T ;
SRIVASTAVA, S ;
MOSTOFI, FK ;
MCLEOD, DG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (16) :1277-1281
[16]   BLACK-WHITE DIFFERENCES IN THE STAGE AT PRESENTATION OF PROSTATE-CANCER IN THE DISTRICT-OF-COLUMBIA [J].
NDUBUISI, SC ;
KOFIE, VY ;
ANDOH, JY ;
SCHWARTZ, EM .
UROLOGY, 1995, 46 (01) :71-77
[17]   EFFECT OF AGE AND RACE ON THE SURVIVAL OF MEN WITH PROSTATE-CANCER IN THE METROPOLITAN DETROIT TRICOUNTY AREA 1973 TO 1987 [J].
PIENTA, KJ ;
DEMERS, R ;
HOFF, M ;
KAU, TY ;
MONTIE, JE ;
SEVERSON, RK .
UROLOGY, 1995, 45 (01) :93-101
[18]  
Powell I J, 1998, Semin Urol Oncol, V16, P221
[19]   REMOVAL OF THE FINANCIAL BARRIER TO HEALTH-CARE - DOES IT IMPACT ON PROSTATE-CANCER AT PRESENTATION AND SURVIVAL - A COMPARATIVE-STUDY BETWEEN BLACK-AND-WHITE MEN IN A VETERANS AFFAIRS SYSTEM [J].
POWELL, IJ ;
SCHWARTZ, K ;
HUSSAIN, M .
UROLOGY, 1995, 46 (06) :825-830
[20]  
Robinson SB, 1996, J NATL MED ASSOC, V88, P241